Making liver cancer cells go ARGh!
- PMID: 36222348
- PMCID: PMC9627661
- DOI: 10.15252/embj.2022112415
Making liver cancer cells go ARGh!
Abstract
A recent study by Missiaen et al (2022) uncovers hepatocellular carcinoma (HCC) cells to downregulate urea cycle enzymes and rely on the uptake of exogenous arginine and GCN2 kinase-dependent cell-cycle arrest for survival. These results offer new avenues for combinatorial targeting of liver cancer.
©2022 The Authors.
Figures
Comment on
-
GCN2 inhibition sensitizes arginine-deprived hepatocellular carcinoma cells to senolytic treatment.Cell Metab. 2022 Aug 2;34(8):1151-1167.e7. doi: 10.1016/j.cmet.2022.06.010. Epub 2022 Jul 14. Cell Metab. 2022. PMID: 35839757 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
